Choosing Hope Over Acute Lymphoblastic Leukemia: Kristin’s Immunotherapy Story
When standard treatments failed to keep Kristin's acute lymphoblastic leukemia at bay, she enrolled in a clinical trial of a CAR T cell therapy. #CIM18 #CancerStories
In 2010, Kristin Kleinhofer was feeling healthy when she found a bump on the ride side of her head and thought it was just a “harmless cyst.” After her mother suggested she see a doctor, Kristin met with an oncologist and she was diagnosed with acute lymphoblastic leukemia. When standard treatments failed to keep Kristin's cancer at bay, she enrolled in a clinical trial of a CAR T cell therapy in 2014. Two weeks before Christmas, a bone marrow biopsy confirmed that the cancer was gone and Kristin was in remission. “It was the best Christmas gift” for Kristin and her entire family. Now, almost four years later, Kristin celebrates life with her family and partner Benny, checking travel and other adventures off her bucket list. http://www.cancerresearch.org/patients.
This video is presented as part of the Cancer Research Institute 6th Annual Cancer Immunotherapy Month awareness campaign in June 2018. Learn more about cancer immunotherapy and its potential to save more lives at http://www.cancerresearch.org/june.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org
-
Category
No comments found